Literature DB >> 32740242

Response to the Comment on "Local Recurrence After TaTME for Rectal Cancer".

Sapho Xenia Roodbeen, Antonino Spinelli1,2,3,4,5, Willem Bemelman6,7,8, Francesca Di Candido1,2,3, Maylis Cardepont9, Quentin Denost9, Andre D'Hoore10, Susan van Dieren11,12, Bert Houben13, Joep J Knol13, Beatriz Martín-Pérez10, Eric Rullier9, Dana Sands14, Ilana Setton14, Katrien Van de Steen13, Pieter J Tanis15, Steven D Wexner14, Albert M Wolthuis10, Roel Hompes15.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 32740242     DOI： 10.1097/SLA.0000000000004090

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  4 in total

1.  Rectal eversion for direct access to the distal resection margin: do we need another tool in the toolbox of rectal cancer surgery?

Authors:  R O Perez; G P São Julião
Journal:  Tech Coloproctol       Date:  2020-08-16       Impact factor: 3.781

2.  Oncological outcomes and stoma-free survival following TaTME, a prospective cohort study.

Authors:  S Hallam; F Ahmed; N Gouvas; S Pandey; D Nicol
Journal:  Tech Coloproctol       Date:  2021-02-19       Impact factor: 3.781

3.  A comparative cost analysis of transanal and laparoscopic total mesorectal excision for rectal cancer.

Authors:  Francesca Di Candido; Michele Carvello; Deborah S Keller; Elena Vanni; Annalisa Maroli; Isacco Montroni; Roel Hompes; Matteo Sacchi; Marco Montorsi; Antonino Spinelli
Journal:  Updates Surg       Date:  2020-09-14

4.  Transanal total mesorectal excision for stage II or III rectal cancer: pattern of local recurrence in a tertiary referral center.

Authors:  Carolina González-Abós; F Borja de Lacy; Yoelimar Guzmán; Sara T Nogueira; Ana Otero-Piñeiro; Raúl Almenara; Antonio M Lacy
Journal:  Surg Endosc       Date:  2021-01-04       Impact factor: 4.584
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.